IM Cannabis Corp. Files Routine 6-K Report

Ticker: IMCC · Form: 6-K · Filed: 2025-05-15T00:00:00.000Z

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

IM Cannabis Corp. filed a standard 6-K, no major news, just keeping the SEC updated.

AI Summary

IM Cannabis Corp. filed a Form 6-K on May 15, 2025, reporting for the month of May 2025. The company, incorporated in Israel with its principal executive offices at Kibbutz Glil Yam, is a foreign private issuer and files annual reports on Form 20-F. The filing does not contain specific financial figures or operational updates beyond its routine reporting status.

Why It Matters

This filing indicates IM Cannabis Corp. is meeting its ongoing disclosure obligations as a foreign private issuer. Investors can monitor these filings for any material updates the company chooses to release.

Risk Assessment

Risk Level: low — This filing is a routine report and does not contain new material information, financial results, or significant corporate actions.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC when they make public certain information that is required to be made or is made public in their country of origin.

When was this specific Form 6-K filed?

This Form 6-K was filed on May 15, 2025.

Where are IM Cannabis Corp.'s principal executive offices located?

IM Cannabis Corp.'s principal executive offices are located at Kibbutz Glil Yam, Central District, Israel.

Does IM Cannabis Corp. file its annual reports on Form 20-F or 40-F?

IM Cannabis Corp. files its annual reports on Form 20-F.

Does this filing contain specific financial results for May 2025?

No, this filing is a routine report for the month of May 2025 and does not contain specific financial results or operational updates.

From the Filing

0001178913-25-001810.txt : 20250515 0001178913-25-001810.hdr.sgml : 20250515 20250515081148 ACCESSION NUMBER: 0001178913-25-001810 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250515 FILED AS OF DATE: 20250515 DATE AS OF CHANGE: 20250515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 25948854 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533153.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of May 2025 .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒  Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____   Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____   Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.   SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     IM CANNABIS CORP.   (Registrant)       Date: May 15, 2025 By: /s/ Oren Shuster   Name:     Oren Shuster   Title: Chief Executive Officer and Director EXHIBIT INDEX   99.1 News Release dated May 15, 2025 99.2 Interim Consolidated Financial Statements for the three months ended March 31, 2025 99.3 Management's Discussion and Analysis for the three months ended March 31, 2025 99.4 Certification of Interim Filings by CFO dated May 15, 2025 99.5 Certification of Interim Filings by CEO dated May 15, 2025 EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 IM CANNABIS CORP. IM Cannabis Reports First Quarter Financial Results   IMC Delivers Net Profit and 87% Gross Margin Improvement in Q1, Reflecting Strategic and Operational Progress.   TORONTO, and GLIL YAM, Israel, May 15, 2025 /PRNewswire/ -- IM Cannabis Corp. (the " Company " or " IMC ") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the first quarter ended March 31, 2025. All amounts are reported in Canadian do

View on Read The Filing